Answers are grounded in this paper and cite their sources.
Octreotide stimulates intestinal motility in normal subjects and in patients with scleroderma. In such patients, the short-term administration of octreotide reduces bacterial overgrowth and improves abdominal symptoms. This agent may be useful for the treatment of intestinal dysmotility in patients with scleroderma.
No takes yet. Share an insight, caveat, or question.
Soudah et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: